NCT02367729

Brief Summary

This study evaluates the effectiveness of a neurostimulator applied to the outer ear for adolescents with functional gastrointestinal disorders. The neurostimulator provides nerve stimulation to a branch of the vagus nerve which is thought to be involved in transmission of pain signals. Half of the study subjects will receive an active nerve stimulator while the other half will receive an inactive one.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2015

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 20, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

October 12, 2018

Completed
Last Updated

November 8, 2018

Status Verified

October 1, 2018

Enrollment Period

1.3 years

First QC Date

February 1, 2015

Results QC Date

May 7, 2018

Last Update Submit

October 11, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Frequency-Severity-Duration Scale (PFSD) Score

    One-page, 6-item pain measure assessing pain symptoms over the past week. Measures the typical and worst pain intensity, frequency and duration over the past week in units on a scale from 0 to 10 (10 being the worst pain imaginable). Worst pain = primary outcome.

    Change from Baseline to Week 4

Secondary Outcomes (4)

  • Nausea Profile

    Change from Baseline to week 4 in Nausea Profile score.

  • State-Trait Anxiety Inventory for Children (STAI-C)

    Change from Baseline (Pre) to 2-3 months after end of therapy (Post)

  • Patient Reported Outcomes Measurement Information System (PROMIS) Pediatric Global Health (PGH-7)

    Change from Baseline (Pre) to 2-3 months after end of therapy (Post)

  • Functional Disability Inventory (FDI)

    Change from Baseline (Pre) to 2-3 months after end of therapy (Post)

Other Outcomes (1)

  • Questionnaire on Pediatric Gastrointestinal Symptoms, Rome III (QPGS-RIII), Reporting the Number of Participants With Specific Diagnoses

    Baseline only (diagnostic criteria)

Study Arms (2)

Neurostimulator

EXPERIMENTAL

Auricular neurostimulator treatment x 5 days each week for 4 consecutive weeks

Device: Neurostimulator

Sham Neurostimulator

SHAM COMPARATOR

Inactive auricular neurostimulator treatment x 5 days each week for 4 consecutive weeks

Device: Sham

Interventions

Non-invasive, battery operated neurostimulator of the external ear worn for 5 days each week x 4 weeks.

Neurostimulator
ShamDEVICE

Inactive neurostimulator device pre-programmed to be inactive. To be worn for 5 days each week x 4 weeks.

Sham Neurostimulator

Eligibility Criteria

Age11 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescents with a major complaint of abdominal pain (minimum 3/10 in severity) with or without nausea (minimum 3/10 in severity) of unclear etiology, who are English-speaking and willing to participate and consent to the study and who have a parent willing to participate.
  • Patients with symptoms of minimum three times per week for a duration of two months or greater
  • Intact external ear that is free of infection or severe dermatological conditions.
  • Stable vital signs for their respective age

You may not qualify if:

  • Medically complex children or those who take a medication or suffer from an organic disease that can explain symptoms will be excluded from participation.
  • Children or parents, who have developmental delay, will be excluded due to difficulties in accurately completing the questionnaires and assessing symptoms.
  • History of seizures
  • Currently implanted electrical device
  • Orthostatic hypotension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

Related Publications (8)

  • Sator-Katzenschlager SM, Wolfler MM, Kozek-Langenecker SA, Sator K, Sator PG, Li B, Heinze G, Sator MO. Auricular electro-acupuncture as an additional perioperative analgesic method during oocyte aspiration in IVF treatment. Hum Reprod. 2006 Aug;21(8):2114-20. doi: 10.1093/humrep/del110. Epub 2006 May 5.

  • Sator-Katzenschlager SM, Szeles JC, Scharbert G, Michalek-Sauberer A, Kober A, Heinze G, Kozek-Langenecker SA. Electrical stimulation of auricular acupuncture points is more effective than conventional manual auricular acupuncture in chronic cervical pain: a pilot study. Anesth Analg. 2003 Nov;97(5):1469-1473. doi: 10.1213/01.ANE.0000082246.67897.0B.

  • Asher GN, Jonas DE, Coeytaux RR, Reilly AC, Loh YL, Motsinger-Reif AA, Winham SJ. Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials. J Altern Complement Med. 2010 Oct;16(10):1097-108. doi: 10.1089/acm.2009.0451.

  • Busch V, Zeman F, Heckel A, Menne F, Ellrich J, Eichhammer P. The effect of transcutaneous vagus nerve stimulation on pain perception--an experimental study. Brain Stimul. 2013 Mar;6(2):202-9. doi: 10.1016/j.brs.2012.04.006. Epub 2012 May 7.

  • Kraus T, Kiess O, Hosl K, Terekhin P, Kornhuber J, Forster C. CNS BOLD fMRI effects of sham-controlled transcutaneous electrical nerve stimulation in the left outer auditory canal - a pilot study. Brain Stimul. 2013 Sep;6(5):798-804. doi: 10.1016/j.brs.2013.01.011. Epub 2013 Feb 13.

  • Sator-Katzenschlager SM, Scharbert G, Kozek-Langenecker SA, Szeles JC, Finster G, Schiesser AW, Heinze G, Kress HG. The short- and long-term benefit in chronic low back pain through adjuvant electrical versus manual auricular acupuncture. Anesth Analg. 2004 May;98(5):1359-64, table of contents. doi: 10.1213/01.ane.0000107941.16173.f7.

  • Krasaelap A, Sood MR, Li BUK, Unteutsch R, Yan K, Nugent M, Simpson P, Kovacic K. Efficacy of Auricular Neurostimulation in Adolescents With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial. Clin Gastroenterol Hepatol. 2020 Aug;18(9):1987-1994.e2. doi: 10.1016/j.cgh.2019.10.012. Epub 2019 Oct 14.

  • Kovacic K, Hainsworth K, Sood M, Chelimsky G, Unteutsch R, Nugent M, Simpson P, Miranda A. Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial. Lancet Gastroenterol Hepatol. 2017 Oct;2(10):727-737. doi: 10.1016/S2468-1253(17)30253-4. Epub 2017 Aug 18.

MeSH Terms

Interventions

Implantable Neurostimulators

Intervention Hierarchy (Ancestors)

Electrodes, ImplantedElectrodesElectrical Equipment and SuppliesEquipment and SuppliesProstheses and Implants

Results Point of Contact

Title
Dr. Katja Kovacic
Organization
Medical College of Wisconsin

Study Officials

  • Katja Kovacic, MD

    Medical College of Wisconsin

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 1, 2015

First Posted

February 20, 2015

Study Start

September 1, 2015

Primary Completion

December 1, 2016

Study Completion

January 1, 2017

Last Updated

November 8, 2018

Results First Posted

October 12, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

Locations